newsfilter
← Latest News
Business Wire·

2seventy bio to Participate in Upcoming Investor Conference

2seventy bio, Inc. (NASDAQ:TSVT), a leading immuno-oncology cell therapy company, announced today that members of the management team will participate in a fireside chat at the upcoming Goldman Sachs 44th Annual Global